🔎 Trials Near Me

Почетна › Карцином на панкреасот › Северна Каролина

Клинички испитувања за Карцином на панкреасот во Северна Каролина

34 студии за Карцином на панкреасот бараат учесници на локации во Северна Каролина.

Градови во Северна Каролина

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Durham VA Medical Center, Durham
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • FirstHealth of the Carolinas, Pinehurst
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07562152

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Durham
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07127874

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  • Duke Cancer Center, Durham
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07621718

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Се регрутираНабљудувачка студија
Возраст од 18 до 130 · Сите полови · Ажурирано 25.9.2026 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Cancer Institute, Charlotte
  • University of North Carolina Hospitals at Hillsborough, Hillsborough
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Duke Cancer Center, Durham
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US035, Chapel Hill
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07522073

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Duke University Medical Center, Durham
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06445062

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0100, Durham
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07492680

Promoting CT Engagement for Pancreatic Cancer With App

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT06252545

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Durham VA Medical Center, Durham
  • East Carolina University, Greenville
  • и уште 1
Се регрутираНабљудувачка студија
Возраст од 50 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT04239573

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • University of North Carolina, Chapel Hill
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07644559

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • University of North Carolina - Gastroenterology and Hepatology, Chapel Hill
  • University of North Carolina, Chapel Hill
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT05245500

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06958328

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

  • Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутираФаза 1
Возраст од 18 до 99 · Сите полови · Ажурирано 19.8.2026 · NCT03454035

A Study of DM002 in Patients With Advanced Solid Tumors

  • Carolina BioOncology Institute, LLC, Huntersville
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 7.8.2026 · NCT06751329

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

  • Levine Cancer Institute, Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 23.7.2026 · NCT05376592

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Duke University Medical Center, Durham
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 15.7.2026 · NCT06937177

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 19 до 110 · Сите полови · Ажурирано 29.6.2026 · NCT02012699

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

  • Duke Cancer Institute /ID# 276267, Durham
  • Carolina BioOncology Institute /ID# 232597, Huntersville
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.6.2026 · NCT05005403

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, Durham
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 10.6.2026 · NCT06835569

Autologous CAR-T Cells Targeting B7-H3 in PDAC

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 8.6.2026 · NCT06158139

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Duke Cancer Center, Durham
  • Carolina BioOncology Institute, Huntersville
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT06040541

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Southeastern Medical Oncology Center-Clinton, Clinton
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville
  • и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06998940

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 23.4.2026 · NCT06483555

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • Carolina BioOncology Institute, Huntersville
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 18.2.2026 · NCT07030257

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Charlotte
  • Ohio State University-Telemedicine, Raleigh
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 17.2.2026 · NCT06906562

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
Се регрутираФаза 2
Возраст од 18 до 99 · Сите полови · Ажурирано 13.1.2026 · NCT03977233

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Levine Cancer Institute, Charlotte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 15.8.2025 · NCT04429542

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • University of North Carolina, Chapel Hill
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 27.6.2025 · NCT03175224

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.3.2025 · NCT05776524

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.